Human prostate cancer stem cells: New features unveiled

Asian Journal of Andrology

Volumn 13, Issue 3, 2011, Pages 355-356

  Sun, Yuting ^a   Gao, Wei Qiang ^b,c  

^a GENENTECH INC   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CASTRATION; CELL SUBPOPULATION; HUMAN; MULTIPOTENT STEM CELL; NONHUMAN; PROSTATE CANCER; SPHEROID CELL;

EID: 79955673748     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.17     Document Type: Article

References (10)

1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-11. (Pubitemid 33041634)
2. Wang ZA, Shen MM. Revisitingtheconcept of cancer stem cells in prostate cancer. Oncogene 2011; 30: 1261-71.
3. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science 2010; 329: 568-71.
4. Rajasekhar VK, Studer L, Gerald W, Socci ND, Scher HI. Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling. Nat Commun 2011; 2: 162.
5. de Marzo AM, Nelson WG, Bieberich CJ, Yegnasubra-manian S. Prostate cancer: new answers prompt new questions regardingcell of origin. Nat Rev Urol 2010; 7: 650-2.
6. Wang X, Kruithof-deJulio M, Economides KD, Walker D, Yu H et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009; 461: 495-500.
7. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J et al. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA 2010; 107: 2610-5.
8. Iliopoulos D, Hirsch HA, Wang G, Struhl K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion. Proc Natl Acad Sci USA 2011; 108: 1397-402.
9. Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 2010; 464: 302-5.
10. Min J, Zaslavsky A, Fedele G, Mc Laughlin SK, Reczek EE et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med 2010; 16: 286-94.